Allstate Investment Management’s Zimmer Biomet ZBH Stock Holding History

Allstate Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.23M	Buy	+9,663	New	+$1.12M	0.04%	303

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allstate Investment Management's ZBH Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Zimmer Biomet (ZBH) in Q4 2022: 9,663 shares worth $1.23M. The stake represents 0.04% of the portfolio and ranks #303 among its holdings.

977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

Allstate Investment Management held 9,663 shares of Zimmer Biomet worth $1.23M as of Q4 2022.
Zimmer Biomet was a new Allstate Investment Management position in Q4 2022.
Zimmer Biomet made up 0.04% of Allstate Investment Management's portfolio in Q4 2022, its #303 holding.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.